Adenosine acts as a neuromodulator through A, and A, receptors.
The adenosine analogs have been recognized, among other effects, as strong depressors of the locomotor activity by acting on striatal A, receptors.
Moreover Any perturbations within the basal ganglia system lead to movement disorders (Albin et al., 1989) . The striatum receiving its main input from the cerebral cortex is the first relay of this system. In turn, its medium-sized spiny neurons accounting for more than 90% of the striatal neurons constitute the output pathways. Although all of them utilize GABA as neurotransmitter (Chesselet and Robins, 1989) , two subpopulations of these efferent neurons have been identified (for review, see Graybiel, 1990 ). The striatopallidal neurons express enkephalin whereas the striatonigral neurons coexpress substance P and dynorphin (Gerfen and Young, 1988; Gerfen et al., 1990; Le Moine et al., 1990, 199 l) , acting finally as an inhibitory and an excitatory pathway to the thalamus, respectively (for review, see Albin et al., 1989) . The dopaminergic nigrostriatal pathway influences differentially these two striatal subpopulations. Reduction ofdopamine input into the striatum decreases substance P expression in striatonigral neurons whereas it increases enkephalin expression in striatopallidal subpopulation (Young et al., 1986; Normand et al., 1988; Gerfen et al., 1990) . Moreover, it has been recently demonstrated that these actions of dopamine are differentially mediated by dopamine D, and D, receptors (Gerfen et al., 1990) , the former being mainly expressed in striatonigral neurons and the latter mainly in striatopallidal neurons (Gerfen et al., 1990; Le Moine et al., 1990, 199 1) . It has been proposed that hyperkinetic states, such as Huntington's disease or hemiballism, and hypokinetic states, such as parkinsonism, all result from disequilibria between these two striatal subpopulations and/or the specific pathways originating from them (Albin et al., 1989) .
Besides dopamine, which is considered as a major regulator of striatal function, adenosine also seems to play a crucial role, far less understood though, in the basal ganglia physiology. Adenosine modulates neuronal functions through receptors that have been classified as A, and A, receptors (Van Calker et al., 1979) . The recent cloning and characterization of the cDNAs encoding adenosine A, and A, receptor subtypes (Libert et al., 1989, 199 1; Maenhaut et al., 1990) histochemistry (Schiffmann et al., , 1991a Schiffmann and Vanderhaeghen, 1992) . The A,, receptor is exclusively expressed by medium-sized neurons of the striatum (Schiffmann et al., 1990, 199 1 b) and mainly by the enkephalinergic striatal subpopulation (Schiffmann et al., 199 la) . The adenosine analogs have been recognized, among other effects (for reviews, see Dunwiddie, 1985; Snyder, 1985) , as strong depressors of the locomotor activity. More recent data strongly suggest that this action is mediated by the striatal A, receptor (Durcan and Morgan, 1989; Ferre et al., 199 la) To understand the influence of adenosine through the A, receptor in the striatum, we studied the anatomical and functional relationships of the A, receptors with the D, and D, receptors.
Materials and Methods
Animals. For the colocalization study, intact adult Wistar rats were killed by decapitation and their brains were frozen and processed for in situ hybridization as follows.
One microliter of a 2.5% solution of fluorogold, a fluorescent retrograde axonal tracer (Gerfen and Young, 1988; Gerfen et al., 1990) , was injected into the substantia nigra of adult Wistar rats anesthetized with chloral hydrate (3 gm/ 100 gm body weight). Stereotaxic injections were placed 5.6 mm posterior to the bregma, 2 mm lateral to the midline, and 8 mm ventral to the surface of the skull, according to the atlas of Paxinos and Watson (1986) . After 10 d, the rats were killed by decapitation and their brains removed, fixed in 4% paraformaldehyde in 0.1 M phosphate-buffered solution (pH 7.4), and thereafter processed for in situ hybridization as follows. Adult Wistar rats were anesthetized with chloral hydrate (3 gm/lOO gm body weight) and 8 fig of 6-hydroxydopamine (6-OHDA) in 4 pl of 0.1% ascorbate and 0.9% saline was injected in the right medial forebrain bundle. Stereotaxic injections were placed 4 mm posterior to the bregma, 1.6 mm lateral to the midline, and 8.2 mm ventral to the surface of the skull, according to the atlas of Paxinos and Watson (1986) . After 18 d, only rats displaying significant apomorphine-induced contralateral rotation behavior (>7 tums/min) were selected. They subsequently received daily intraperitoneal injections of saline or caffeine ( Treated rats were killed by decapitation 3 hr after the last injection, and their brains were frozen and processed for in situ hybridization as follows.
In situ hybridization histochemistry. Serially cut 15-pm-thick sections, or 4-5-pm-thick sections for the colocalization analysis, were thawmounted onto slides coated with poly-L-lysine and stored at -20°C until use.
With the exception of sections from already fixed fluorogold-injected brains, the sections were immersed in a 4% paraformaldehyde solution for 30 min and rinsed. All sections were dehydrated and dipped for 5 min in chloroform. After air drying, the sections were incubated overnight at 37°C or 42°C with 0.8 x IO6 cpm per section of YS-labeled probes (4-8 x lo8 cpm/pg) diluted in hybridization buffer, which consisted of 50% formamide (Fluka), 4 x SSC (1 x SSC: 0.15 M NaCl, 0.0 15 M sodium citrate, pH 7.4), Ix Denhardt's solution (0.02% each of polyvinylpyrrolidone, bovine serum albumin, Ficoll), 1% sarcosyl, 0.02 M sodium phosphate at pH 7.4,10% dextran sulfate, yeast tRNA (Sigma) at 500 &ml, salmon sperm DNA (Sigma) at 100 &ml, and 60 mM dithiothreitol (Sigma). After hybridization, the sections were rinsed for 4 x 15 min in 1 x SSC at 45°C or 55"c, covered with Hyperfilm @-max him (Amersham) for 5-12 d, and thereafter dipped in Kodak NTB3 emulsion for 4-7 weeks.
The specificity of in situ hybridization was assessed by the comparison of localizations of the different mRNAs in adjacent sections using these oligonucleotide probes of the same size and similar guanosine-cytosine content. This demonstrated different distributions throughout the brain that agreed with the previous reports. In addition, an extinction of the signal was observed after RNase (Sigma) pretreatment or after incubation with labeled probe in the presence of excess cold probe.
Oligonucleotide probes. Forty-four-mer oligonucleotides were synthesized on an Applied Biosystems 38 1A DNA synthesizer. The adenosine A,, receptor (A2r) probe was complementary to nucleotides 9 16-959, the enkephalin probe to nucleotides 105-148; the substance P probe to nucleotides 124-167; the D, probe to nucleotides 539-582, and the D, probe to nucleotides 688-731; of the dog adenosine A,, receptor (RDCI in Libert et al., 1989) , rat preproenkephalin A (Howells et al,, 1984) substance P (Krause et al., 1987) , D, dopamine receptor (Bunzow et al., 1988) and D, dopamine receptor (Sunahara et al., 1990) Figure 3 . Histograms representing, for enkephalin (A, C, E) and substance P (B, D, F), the ratio ( f SEM) of labeling as measured in arbitrary OD units in the lesioned versus the intact striatum in the 6-OHDA-lesioned animals (A, B), the OD values (+SEM) in the lesioned and the intact striatum in the 6-OHDA-lesioned animals (C, D), and the OD values (+ SEM) in the striatum of intact animals (E, F). Statistical analysis using two-tailed Student's t test demonstrates significant changes. A: *, p < 0.001. B: *, p < 0.002. c: #, p < 0.001 6-OHDA + saline versus intact + saline; ##, p < 0.005 6-OHDA + caffeine versus intact + caffeine; *, p < 0.05 intact + caffeine versus intact + saline; **, p < 0.02 6-OHDA + caffeine versus 6-OHDA + saline. D: #, p < 0.001 6-OHDA + saline versus intact + saline; ##, p < 0.005 6-OHDA + caffeine versus intact + caffeine; *, p < 0.02 intact + caffeine versus intact + saline. E: *, p < 0.001 versus saline; #, p < 0.005 caffeine + NECA versus caffeine and caffeine + CHA. F: *, p < 0.0 1 versus saline; **, p < 0.00 1 versus saline; ***, p < 0.0 1 versus caffeine; #, p -c 0.03 versus caffeine; ##, p < 0.001 versus caffeine + CHA. digitized images of 5 12 x 5 12 pixels with 256 gray levels. The borders intact rats receiving chronic treatments, the mean of the corrected ODs of the measuring fields were interactively defined, and the average ODs in the right and left striatum was used as the final OD value in each were calculated. On each section, the average OD over a white matter section. These results expressed in arbitrary OD units (see Fig. 3C -8') area taken as a background level was subtracted from that of the left or in L:I ratio (see Fig. 3A .B) were plotted in the Figure 3 . They were and right dorsal striatum to obtain a corrected OD value. In unilarerally statistically analyzed using the two-tailed Student's t test. In Figures 4  dopamine-depleted rats, the ratio between corrected ODs in the lesioned and 5, representative autoradiograms were taken to illustrate these quanand intact striatum (LI ratio) was calculated in each section. For the titative data. 
Results

Phenotypic characterization of striatal neurons expressing the A,, receptor
The expression of A,, receptor, substance P, enkephalin, D,, and D, receptors was assessed in the striatopallidal and striatonigral neurons using in situ hybridization combined with retrograde fluorogold labeling of striatonigral neurons. A large proportion of fluorogold-labeled striatonigral neurons express substance P (147 of 18 1) and the D, receptor (149 of 183), while a small proportion of these neurons express enkephalin (13 of 207) the D, receptor (11 of 171), and the A,, receptor (3 of 163) (Fig. IA-E) . The majority of neurons that express enkephalin (157 of 170), the D, (166 of 177), and the A,, (149 of 152) receptors are fluorogold negative (Fig. IA-C) and are assumed to be striatopallidal neurons (Get-fen et al., 1990) . To address more directly the putative coexpression of A,, with D, or D, receptors in individual striatal neurons, hybridization was performed on thin (5pm-thick) adjacent sections alternatively with the A,, probe and the D, or the D, probes. Although significant results were previously obtained using the same approach (Burgunder and Young, 1989; Weiner et al., 1990; Schiffmann et al., 199la) , the inability to recognize all neurons in these thin adjacent sections results in some limitations since only portions of the total neuronal population were taken into account. The neurons expressing the A,, receptor often contain D, receptor transcripts (120 of 126) ( Fig. 2A,B) , while they seldom express D, receptor (3 of 87) (Fig. 2C,D) . On the other hand, 120 out of 125 D, receptor-expressing neurons and 3 out of I 11 D, receptor-expressing neurons also contain A,, receptor transcripts. The large cholinergic neurons that never express A,, receptor (Schiffmann et al., 199 1 a) were excluded. Adenosine A, receptor-regulated gene expression of striatonigral and striatopallidal neurons Since the A,, and D, receptors have opposite effects on adenylyl cyclase (Van Calker et al., 1979; Stoof and Kebabian, 198 1) and dopamine/adenosine interactions have been described (Ferre et al., 199la, b) , we examined the regulatory effect of A, receptor on striatal gene expression.
Rats unilaterally depleted in dopamine by an unilateral 6-OHDA-induced lesion of the right nigrostriatal pathway subsequently received chronic saline or caffeine treatments. In the saline-treated animals, the mean ratio between OD in the 6-OHDA-lesioned striatum and the intact striatum (L:I ratio) was 2.33 for enkephalin mRNA (Figs. 3A, 4A ) and 0.54 for substance P mRNA (Figs. 3B, 4C ). In the animals subsequently treated with caffeine, this L:I ratio of enkephalin mRNA was dramatically reduced to 1.45 (Fig. 3A ) and the L:I ratio of substance P mRNA was slightly increased to 0.78 (Fig. 3B) . However, when the absolute values of OD were considered, it appeared that the dramatic reduction ofthe L:I ratio for enkephalin mRNA was due not only to a significant 19% decrease in the lesioned side but also to a significant 32% increase in the intact side (Figs. 3C, 4B ). In contrast, the caffeine-induced increase of the L:I ratio for substance P mRNA was only due to a significant 24% decrease in the intact side without any significant changes in the lesioned side (Figs. 30, 40) .
Modifications of striatal enkephalin and substance P expression were similarly analyzed in four groups of intact rats treated with either saline, caffeine alone, caffeine with NECA (an equipotent A, and A, agonist), or caffeine with CHA (a more selective A, agonist) (Bruns et al., 1986) . Caffeine, as compared to saline, significantly increased OD values for enkephalin mRNA by 67% (Figs. 3E, 5C ) and decreased OD values for substance P mRNA G by 26% (Figs. 3F, 5D ). Moreover, these caffeine-induced modifications were significantly reversed by a concomitant treatment with NECA but not by a concomitant treatment with CHA (Figs. 3E,F, 5E-H).
Discussion
The main findings of this study are the nearly exclusive coexpression of A,, receptors and D, receptors by the striatopallidal neurons and the two opposite ways by which adenosine and its antagonist, caffeine, regulate through A, receptors, the neuropeptide gene expression in the striatum.
As has been previously demonstrated (Gerfen and Young, 1988; Burgunder and Young, 1989; Weiner et al., 1990; Schiffmann et al., 199 la) , significant results were obtained in the first part of this study both for colocalization using different radiolabeled probes on thin adjacent sections and for the characterization of the projections of labeled neurons by combination of retrograde labeling with in situ hybridization. These results un-doubtedly demonstrate a main coexpression of A,, and D, receptors in striatopallidal neurons but not of A,, and D, receptors in striatonigral neurons as already suggested by the main coexpression of enkephalin and A,, receptor mRNAs (Schiffmann et al., 199la) .
The experiments of gene expression regulation demonstrate two sites of action of A, receptor in the striatum. First, as expected from the A,,-D, receptor coexpression in the enkephalinergic striatopallidal neurons and from their stimulatory and inhibitory actions on the adenylyl cyclase, respectively, they have opposite effects in striatopallidal neurons: A, blockade, like D, stimulation (Gerfen et al., 1990) , decreases specifically enkephalin gene expression. Behavioral studies in rodents have suggested that stimulation of striatal A, receptor causes an inhibition of responses elicited by D, activation (Ferre et al., 199 1 a). The mechanism described above could be interpreted as the molecular and cellular events leading to these observations. However, this A, receptor effect was revealed only when the nigrostriatal dopaminergic pathway was disrupted. This would suggest, therefore, the involvement of adenosine receptors in the regulation of striatal gene expression through a second mechanism that depends on the integrity of the dopaminergic fibers. Caffeine induced an increase in enkephalin mRNA and a decrease in substance P mRNA in the intact rats striatum and in the intact striatum of 6-OHDA-lesioned rats through blockade of an A, receptor. This could be inferred from the effects of NECA, an equipotent A, and A, agonist, and CHA, a selective A, agonist on the caffeine-induced modifications. Indeed, NECA completely reversed these caffeine-induced modifications while CHA did not exhibit any effect. Considering that the equipotent A, and A, agonist NECA possesses a IO-fold lower potency at the A, receptor than the A, agonist CHA (Bruns et al., 1986) , it is doubtful that an A, receptor was involved in the effect of NECA. Therefore, in this condition, the equipotent A, and A, agonist NECA most probably acted on an A, receptor. Like the chronic caffeine treatment, a 6-OHDA lesion ofthe nigrostriatal pathway, resulting in a striatal dopamine depletion, also induced an increase of enkephalin mRNA associated with a decrease of substance P mRNA (see Results; see also Young et al., 1986; Normand et al., 1988; Gerfen et al., 1990) . A chronic caffeine treatment could result in a relative dopamine depletion by the blockade of presynaptic A, receptors located on nigrostriatal terminals. Indeed, it has been reported that these receptors stimulate synaptic tyrosine hydroxylase activity (Onali et al., 1988) and striatal dopamine release (Zetterstriim and Fillenz, 1990) . While it remains to be confirmed, these presynaptic receptors could be of the A,, subtype (Bruns et al., 1986) . This is suggested by the failure to detect A,, receptor mRNA in the substantia nigra and by the fact that CGS2 1680, a selective A,, receptor agonist (Lupica et al., 1990) failed to stimulate striatal dopamine release (Lupica et al., 1990) converse to other A, agonists (Onali et al., 1988; Zetterstrom and Fillenz, 1990) .
Although more doubtful, other mechanisms leading to the effects of caffeine in the intact striatum could also be proposed. Indeed, the gene expression of substance P and enkephalin in striatal medium-sized neurons is also regulated by glutamatergic and cholinergic fibers (Uhl et al., 1988; Somers and Beckstead, 1990; Pollack and Wooten, 1992) . Like the dopaminergic terminals, these fibers exhibit presynaptic adenosine receptors. The releases of glutamate and ACh are modulated by A, receptors (Fredholm and Dunwiddie, 1988) and both A, and A, receptors (Fredhiilm and Dunwiddie, 1988; Brown et al., 1990 ) respectively. However, converse to dopamine, glutamate and ACh regulate substance P and enkephalin gene expression in the same direction (Somers and Beckstead, 1990; Pollack and Wooten, 1992) . Blockade of the enzyme glutamine synthetase or cortical cerebral aspiration lesions resulted in a decrease of both substance P and enkephalin mRNAs (Somers and Beckstead, 1990) . Scopolamine, a muscarinic antagonist, reduced the 6-OHDAinduced increase in enkephalin mRNA and decreased the substance P mRNA level in the intact striatum (Pollack and Wooten, 1992) . It would therefore be expected that, by acting on adenosine receptors located on either glutamatergic or cholinergic terminals, caffeine modifies substance P and enkephalin mRNA levels in the same direction. Conversely, in the present study, caffeine increased enkephalin mRNA and decreased substance P mRNA. Finally, other complex but not fully understood mechanisms could be also involved in the caffeine-induced changes in gene expression in the intact striatum, such as the existence of unidentified adenosine receptor subtypes.
Adenosine through the A, receptor is involved in at least two different regulatory mechanisms in the basal ganglia physiology. First, it stimulates the dopamine release, reinforcing the opposite effect of dopamine on striatonigral and striatopallidal neurons mediated by D, and D, receptors, respectively (Gerfen et al., 1990) . On the other hand, its stimulatory effect directed specifically on striatopallidal neurons counteracts the inhibitory action of dopamine through D, receptor. This effect is particularly revealed in the case of striatal dopamine depletion as encountered in Parkinson's disease characterized by reduced voluntary movements (Homykiewicz, 1963) . To counteract the hyperactivity of the striatopallidal pathway resulting from the dopamine depletion and therefore from the loss of the inhibitory action of dopamine through D, receptor, our data suggest that, in addition to dopamine agonist treatments, selective A,, antagonists should be useful. They should widen the therapeutical arsenal against Parkinson's disease and other syndromes characterized by parkinsonism.
On the other hand, whatever might be the mechanisms involved, this study reveals that caffeine's capacity to modify gene expression in a major structure of the basal ganglia circuitry could account, in animal models, for the effects of caffeine on motor activity. They could be partly related to the well-recognized behavioral effects of caffeine consumption in humans.
Note added in proofs: In the course of submission of the present article, the rat adenosine A,, (Fink et al., 1992) and A,, (Stehle et al., 1992) receptors have been cloned. The coexpression of the A,, and D, receptors has been demonstrated in striatal neurons (Fink et al., 1992) . Although Northern blot analysis demonstrated an A,, receptor expression in the brain, no signal could be detected using in situ hybridization (except in the hypophyseal pars tuberalis) (Stehle et al., 1992) . Therefore, further studies will be necessary to clarify the A,, receptor distribution.
